Lusochimica Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NIMODIPINE, with a corresponding US DMF Number 14979.
Remarkably, this DMF maintains an Active status since its submission on July 26, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 18, 2019, and payment made on June 07, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II